Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (Q80201780)
Jump to navigation
Jump to search
scientific article published on 01 September 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate |
scientific article published on 01 September 2006 |
Statements
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (English)
R N Maini
P C Taylor
J Szechinski
J Bröll
G Balint
P Emery
F Raemen
J Petersen
J Smolen
D Thomson
T Kishimoto
CHARISMA Study Group
1 September 2006